These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436 [TBL] [Abstract][Full Text] [Related]
43. Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. Botti E; Spallone G; Caruso R; Monteleone G; Chimenti S; Costanzo A Curr Pharm Biotechnol; 2012 Aug; 13(10):1861-7. PubMed ID: 22250707 [TBL] [Abstract][Full Text] [Related]
44. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
45. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195 [TBL] [Abstract][Full Text] [Related]
46. Psoriasis in humans is associated with down-regulation of galectins in dendritic cells. de la Fuente H; Perez-Gala S; Bonay P; Cruz-Adalia A; Cibrian D; Sanchez-Cuellar S; Dauden E; Fresno M; García-Diez A; Sanchez-Madrid F J Pathol; 2012 Oct; 228(2):193-203. PubMed ID: 22271227 [TBL] [Abstract][Full Text] [Related]
47. The immunogenetics of Psoriasis: A comprehensive review. Harden JL; Krueger JG; Bowcock AM J Autoimmun; 2015 Nov; 64():66-73. PubMed ID: 26215033 [TBL] [Abstract][Full Text] [Related]
48. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis. Mashiko S; Mehta H; Bissonnette R; Sarfati M J Dermatol Sci; 2017 Nov; 88(2):167-174. PubMed ID: 28743611 [TBL] [Abstract][Full Text] [Related]
49. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. Lovato P; Norsgaard H; Tokura Y; Røpke MA J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805 [TBL] [Abstract][Full Text] [Related]
50. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242 [TBL] [Abstract][Full Text] [Related]
51. Xenotransplantation Model of Psoriasis. Di Domizio J; Conrad C; Gilliet M Methods Mol Biol; 2017; 1559():83-90. PubMed ID: 28063039 [TBL] [Abstract][Full Text] [Related]
52. Involvement of IL-17F via the induction of IL-6 in psoriasis. Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256 [TBL] [Abstract][Full Text] [Related]
53. Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients. Haider AS; Lowes MA; Gardner H; Bandaru R; Darabi K; Chamian F; Kikuchi T; Gilleaudeau P; Whalen MS; Cardinale I; Novitskaya I; Krueger JG J Immunol; 2007 Jun; 178(11):7442-9. PubMed ID: 17513795 [TBL] [Abstract][Full Text] [Related]
54. The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis. Kim TG; Kim SH; Lee MG Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295520 [TBL] [Abstract][Full Text] [Related]